Both in Diagnostics
Immucell vs VolitionRx Limited
Over the past year ICCC returned +68.3% and VNRX returned −97.5%; their daily moves had a correlation of -0.03.
ICCC +68.3% VNRX −97.5%Growth of $1, one year, split-adjusted
| Metric | ICCC | VNRX |
|---|---|---|
| Price | $10.45 | $0.2159 |
| Market cap | $94.9M | $6.5M |
| Today | +1.85% | +10.55% |
| 1 month | +7.2% | −8.1% |
| 6 months | +19.8% | −91.0% |
| Year to date | +69.9% | −95.8% |
| 1 year | +71.6% | −97.5% |
| Revenue growth (YoY) | +11.5% | −2.0% |
| Gross margin | 33.9% | 100.0% |
| Net margin | 25.5% | −1953.1% |
| P/E (TTM) | 120.5× | — |
| Price / sales | 3.1× | 2.6× |
| Net cash | $557.3K | -$8.3M |
| Dividend yield | — | — |
| Volatility (60d) | 37.6% | 117.9% |
| Short % of float | 0.3% | 5.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).